Page 2 - மருத்துவ ப்ராடக்ட்ஸ் பிரிவு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருத்துவ ப்ராடக்ட்ஸ் பிரிவு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருத்துவ ப்ராடக்ட்ஸ் பிரிவு Today - Breaking & Trending Today

Diabetes medication recalled amid carcinogen concerns


Diabetes medication recalled amid carcinogen concerns
03/16/2021 03:46 PM
Photo courtesy of the FDA
Taipei, March 16 (CNA) Kotang X.R. 500mg tablets, a diabetes drug prescribed in Taiwan, are being recalled for risk control purposes out of concern that the product may contain a carcinogenic ingredient, the nation s Food and Drug Administration (FDA) said Tuesday.
The producer, Nantou County-based Shou Chan Industrial Co., took the initiative to recall 16 million tablets of the drug, the main ingredient of which is metformin, a first-line medication for the treatment of type 2 diabetes, the FDA said.
The company has said it did so in a move aimed at risk control. It gave no further explanation, the agency said. ....

T Ai Pei , Elizabeth Hsu , Chang Ming Hsuan , Drug Administration , Medicinal Products Division , Nantou Shou Chan Industrial Co , Products Division , டி ஐ பேய் , எலிசபெத் ஶூ , மருத்துவ ப்ராடக்ட்ஸ் பிரிவு , நண்த்தோ ஶூ சான் தொழில்துறை இணை , ப்ராடக்ட்ஸ் பிரிவு ,

Taiwan recalls Japanese vitamin B supplements due to degradation


Taiwan recalls Japanese vitamin B supplements due to degradation
02/05/2021 11:25 PM
Photo courtesy of the FDA
Taipei, Feb. 5 (CNA) Some 900,000 Japanese-made vitamin B complex supplements are being recalled because they were found to have lost their potency over time, Taiwan s Food and Drug Administration (FDA) said Friday.
The recall is for the VITRIC Tablets brand dietary supplement produced by Japanese firm Kobayashi Pharmaceutical Co.
The Taipei-based Shiang Chuan Brother Trading Co., which represents the brand in Taiwan, has until March 2 to complete the recall of the tablets (batch numbers: T8DS01, T8DS02, T8DS3 and T8DS04), said Hung Kuo-teng (洪國登), who heads the FDA s Medicinal Products Division. ....

T Ai Pei , Shiang Chuan , Ko Lin , Chang Ming Hsuan , Journal Of Research Pharmacy , Shiang Chuan Brother Trading Co , Drug Administration , Medicinal Products Division , Kobayashi Pharmaceutical Co , Kobayashi Pharmaceutical , Hung Kuo Teng , Research Pharmacy , Pharmaceutical Affairs Act , டி ஐ பேய் , கோ லின் , இதழ் ஆஃப் ஆராய்ச்சி மருந்தகம் , மருத்துவ ப்ராடக்ட்ஸ் பிரிவு , கோபயாஷி மருந்து இணை , கோபயாஷி மருந்து , தொங்கவிடப்பட்டது குவோ டெங் , ஆராய்ச்சி மருந்தகம் , மருந்து வாழ்க்கைத்தொழில்கள் நாடகம் ,

Taiwan recalls cancer drugs containing extraneous material


Taiwan recalls cancer drugs containing extraneous material
01/19/2021 03:45 PM
A TTY Biopharm production line. CNA file photo
Taipei, Jan. 19 (CNA) A total of 9,000 cancer drugs manufactured by the Taiwanese company TTY Biopharm Company Limited are being recalled because they were found to contain extraneous material, Taiwan s Food and Drug Administration (FDA) said Tuesday.
The drugs include Gemmis injection 38 mg/ml, which is usually used in combination with other medicines such as Gemcitabine and paclitaxel to treat cancer of the lungs, pancreas, bladder and breast in specific cases, the FDA said.
The contamination of the 9,000 cancer drugs with extraneous material was discovered after a hospital reported such findings to the FDA in December 2020, said Hung Kuo-teng (洪國登), head of the FDA s Medicinal Products Division. ....

T Ai Pei , Joseph Yeh , Biopharm Company , Drug Administration , Medicinal Products Division , Company Limited , Hung Kuo Teng , Chen Wei Ting , டி ஐ பேய் , ஜோசப் ஆமாம் , பிோபர்ம் நிறுவனம் , மருத்துவ ப்ராடக்ட்ஸ் பிரிவு , நிறுவனம் வரையறுக்கப்பட்டவை , தொங்கவிடப்பட்டது குவோ டெங் , சென் வெய் டிங் ,

FDA recalls 9,000 vials of cancer medicine Gemmis


FDA recalls 9,000 vials of cancer medicine Gemmis
Staff writer, with CNA
The Food and Drug Administration (FDA) yesterday said it has ordered TTY Biopharm Co Ltd (台灣東洋藥品) to recall 9,000 vials of a cancer drug after they were found to have been contaminated by extraneous material.
The drug, Gemmis Injection, is sold in 38ml vials and is usually used in combination with other medicines, such as gemcitabine and paclitaxel, to treat cancer of the lungs, pancreas, bladder or breast in specific cases, the FDA said.
The FDA urged people using Gemmis not to stop using it on their own and to ask their doctor to prescribe alternate medication. ....

Biopharm Co Ltd , Drug Administration , Medicinal Products Division , Drug Administration Web , Gemmis Injection , Hung Kuo Teng , Pharmaceutical Affairs Act , The Taipei Times , பிோபர்ம் இணை லிமிடெட் , மருத்துவ ப்ராடக்ட்ஸ் பிரிவு , தொங்கவிடப்பட்டது குவோ டெங் , மருந்து வாழ்க்கைத்தொழில்கள் நாடகம் , தி தைப்பே முறை ,